About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Venetoclax Plus Inotuzumab for B-ALL | Clinical Trials | Clareo Health

Active Not RecruitingPhase 1

Venetoclax Plus Inotuzumab for B-ALL

A Phase 1 Study of Venetoclax in Combination With Inotuzumab Ozogamicin for B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT05016947•Dana-Farber Cancer Institute

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

B-cell Acute Lymphoblastic LeukemiaB-Cell LymphomaALL

Interventions

Venetoclax

Dexamethasone

+1 more

Locations

2

United States

Locations (2)

Brigham and Women's Hospital

Boston, Massachusetts, United States

Dana Farber Cancer Institute

Boston, Massachusetts, United States

Key Dates

Start Date

September 24, 2021

Primary Completion Date

July 10, 2023

Completion Date

December 23, 2026

Last Updated

January 29, 2026

Related Studies

RECRUITINGPhase 2

Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer

NCT06204094

Locally Advanced Rectal Cancer

RECRUITINGPhase 3

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

NCT05671510

Non Small Cell Lung Cancer

RECRUITINGPhase 1/2

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

NCT06043817

Non-Small Cell Lung CancerNSCLC+1 more

RECRUITINGPhase 1

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937

Small Cell Lung CancerMelanoma+2 more

RECRUITINGPhase 2

ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC

NCT06426511

Lung Cancer, Nonsmall Cell

RECRUITINGPhase 1/2

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

CancerColorectal Cancer+13 more

View all related studies

Sponsors

Lead Sponsor

Dana-Farber Cancer Institute

Collaborators

AbbVie

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions